NEW YORK, May 14, 2023 /PRNewswire/ — The intrauterine contraceptive devices (IUD) market size is estimated to grow by USD 965.49 million during 2023-2027. However, the growth momentum will be progressing at a CAGR of 3.98% during the forecast period. The market is segmented by Type (Hormonal intrauterine device and Copper intrauterine device), End-user (Hospitals, Gynecology Clinics, and Others), and Geography (North America, Europe, APAC, and Rest of the World (ROW)). The intrauterine devices market share growth by the hormonal intrauterine device segment will be significant during the forecast period.
Information Services Market Insights –
- Vendors: 15+, Including AbbVie Inc., Bayer AG, DKT International, Durbin PLC, EurimPharm Arzneimittel GmbH, EUROGINE SL, Gima Spa, HLL Lifecare Ltd., Krishco Medical Products Pvt. Ltd., Laboratoire HRA Pharma SAS, Melbea Innovations Ltd., Meril Life Sciences Pvt. Ltd., Ocon Medical Ltd., Pregna International Ltd, Prosan International BV, SMB Corp. of India, TESPRO LLC, The Cooper Companies Inc., TRIMEDIC SUPPLY NETWORK Ltd., Viatris Inc., among others
- Coverage: Parent market analysis; key drivers, major trends, and challenges; customer and vendor landscape; vendor product insights and recent developments; key vendors; and market positioning of vendors
- Segments: Type (Hormonal intrauterine device and Copper intrauterine device), End-user (Hospitals, Gynecology clinics, and Others), and Geography (North America, Europe, APAC, and Rest of World (ROW))
Insights on the market contribution of various segments, including country- and region-wise data, historic data (2017 to 2021), and forecast market size (2023 to 2027), request a sample report
Intrauterine contraceptive devices (IUD) market – Customer Landscape
To help companies evaluate and develop growth strategies, the report outlines –
- Key purchase criteria
- Adoption rates
- Adoption lifecycle
- Drivers of price sensitivity
- For highlights on customer landscape analysis, download a sample!
Global Intrauterine contraceptive devices (IUD) market – Vendor Insights
The growing competition in the market is compelling vendors to adopt various growth strategies such as promotional activities and spending on advertisements to improve the visibility of their services. Technavio report analyzes the market’s competitive landscape and offers information on several market vendors including:
- AbbVie Inc.
- Bayer AG
- DKT International
- Durbin PLC
- EurimPharm Arzneimittel GmbH
- EUROGINE SL
- Gima Spa
- HLL Lifecare Ltd.
- Krishco Medical Products Pvt. Ltd.
- Laboratoire HRA Pharma SAS
- Melbea Innovations Ltd.
- Meril Life Sciences Pvt. Ltd.
- Ocon Medical Ltd.
- Pregna International Ltd
- Prosan International BV
- SMB Corp. of India
- TESPRO LLC
- The Cooper Companies Inc.
- TRIMEDIC SUPPLY NETWORK Ltd.
- Viatris Inc.
Global Intrauterine Contraceptive Devices (IUD) Market – Market Dynamics
Market Drivers
- Increasing rate of unintended pregnancies and unwanted abortions
- Initiatives by government and non-profit organizations
- High growth of e-commerce platforms
Market Trends
- Long-term efficacy and increased acceptance
- Technological advances
- Awareness programs by governments and competitors
Market Challenges
- Adverse effects of IUD
- High-cost constraints
- Lack of reimbursement
Drivers, & Challenges have an impact on market dynamics and can impact businesses. Find some insights from a sample PDF report!
The intrauterine contraceptive devices (IUD) market report provides critical information and factual data, with a qualitative and quantitative study of the market based on market drivers and limitations as well as future prospects.
Why Buy?
- Add credibility to strategy
- Analyzes competitor’s offerings
- Get a holistic view of the market
Grow your profit margin with Technavio- Buy the Report
What are the key data covered in this Intrauterine Contraceptive Devices (IUD) Market report?
- CAGR of the market during the forecast period
- Detailed information on factors that will drive the growth of the Intrauterine Contraceptive Devices (IUD) Market between 2023 and 2027
- Precise estimation of the size of the Intrauterine Contraceptive Devices (IUD) Market size and its contribution to the market in focus on the parent market
- Accurate predictions about upcoming trends and changes in consumer behavior
- Growth of the Intrauterine Contraceptive Devices (IUD) Market industry across North America, Europe, APAC, and Rest of World (ROW)
- A thorough analysis of the market’s competitive landscape and detailed information about vendors
- Comprehensive analysis of factors that will challenge the growth of Intrauterine Contraceptive Devices (IUD) Market vendors
Gain instant access to 17,000+ market research reports.
Technavio’s SUBSCRIPTION platform
Related Reports:
Female Contraceptive Market- The Female Contraceptive Market is estimated to grow at a CAGR of 5.32% between 2022 and 2027. The size of the market is forecast to increase by USD 5,142.22 million.
Emergency Contraceptive Pills Market- The emergency contraceptive pills market is estimated to grow at a CAGR of 4.83% between 2022 and 2027. The size of the market is forecast to increase by USD 258.7 million.
|
Intrauterine Contraceptive Devices (IUD) Market Scope |
|
|
Report Coverage |
Details |
|
Base year |
2022 |
|
Historic period |
2017-2021 |
|
Forecast period |
2023-2027 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 3.98% |
|
Market growth 2023-2027 |
USD 965.49 million |
|
Market structure |
Fragmented |
|
YoY growth 2022-2023 (%) |
3.68 |
|
Regional analysis |
North America, Europe, APAC, and Rest of World (ROW) |
|
Performing market contribution |
North America at 33% |
|
Key countries |
US, China, Japan, Germany, and France |
|
Competitive landscape |
Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks |
|
Key companies profiled |
AbbVie Inc., Bayer AG, DKT International, Durbin PLC, EurimPharm Arzneimittel GmbH, EUROGINE SL, Gima Spa, HLL Lifecare Ltd., Krishco Medical Products Pvt. Ltd., Laboratoire HRA Pharma SAS, Melbea Innovations Ltd., Meril Life Sciences Pvt. Ltd., Ocon Medical Ltd., Pregna International Ltd, Prosan International BV, SMB Corp. of India, TESPRO LLC, The Cooper Companies Inc., TRIMEDIC SUPPLY NETWORK Ltd., and Viatris Inc. |
|
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period |
|
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/
SOURCE Technavio
